2024 Bntx stocks - Average Volume (3M) 692.88K. Market Cap. $23.63B. Enterprise Value $9.96B. Total Cash (Recent Filing) €13.88B. Total Debt (Recent Filing) €212.20M. Price to Earnings (P/E) 8.5. Beta 0.70. Next Earnings.

 
8.04. Market cap. 23.49bn USD. EPS (TTM) 12.30. USD. Data delayed at least 15 minutes, as of Nov 24 2023 18:00 GMT. Latest BioNTech SE (BNTX:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.. Bntx stocks

BioNTech SE (ADR) share price in real-time (A2PSR2 / US09075V1026), charts and ... Frankfurt Stock Exchange · Securities · Trading · Glossary · Publications ...BNTX Stock: Mixed Performance and Challenges in Profitability and Growth. On November 6, 2023, BNTX stock showed mixed performance based on the available data. BNTX is a company in the Health Technology sector, specifically in the Biotechnology industry. With a market cap of $23.2 billion, BNTX is a significant player in the biotech field.Debuting at $14.24 per share, BioNTech’s stock price peaked at $112.76 per share on November 10, 2020, when news broke that that company’s vaccination candidate for the novel COVID-19 virus ...BNTX : 98.83 (+0.89%) SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX PR Newswire - Tue Oct 17, 7:35PM CDT. /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ("BioNTech" or the "Company") (NASDAQ: BNTX). Stock Price Forecast ... The 16 analysts offering 12-month price forecasts for BioNTech SE have a median target of 124.69, with a high estimate of 264.82 and a ...Oct 14, 2023 · The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the ... Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Find the latest Exxon Mobil Corporation (XOM) stock quote, history, news and other vital information to help you with your stock trading and investing.US09075V1026. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2 ...U. J. Alexander. BioNTech ( NASDAQ: BNTX) said it started a phase 1 trial of an mRNA-based malaria vaccine BNT165b1. BNT165b1 is the first candidate from the company's BNT165 program, to develop a ...Nov 22, 2023 · BioNTech SE (NASDAQ:BNTX) posted its quarterly earnings results on Monday, November, 6th. The company reported $0.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $1.26. The firm had revenue of $895.30 million for the quarter, compared to analysts' expectations of $850.50 million. everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we're working on revolutionary approaches in ...BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Adobe Stock Forecast 12-08-2023. Forecast target price for 12-08-2023: $ 640.37. Positive dynamics for Adobe shares will prevail with possible volatility of 2.946%. Pessimistic target level: 632.88. Optimistic target level: 652.09.See the latest Baidu Inc ADR stock price (BIDU:XNAS), related news, valuation, dividends and more to help you make your investing decisions.BioNTech (NASDAQ:BNTX – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a research note issued to investors on Friday, Marketbeat.com reports.They currently have a $99.00 target price on the stock, down from their previous target price of $106.00. JPMorgan …On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product.The stock of BioNTech SE ADR (BNTX) has gone down by -2.01% for the week, with a 3.63% rise in the past month and a -20.46% drop in the past quarter. The volatility ratio for the week is 3.45%, and the volatility levels for the past 30 days are 3.21% for BNTX. The simple moving […]The consensus among . 4 Wall Street analysts covering (NASDAQ: BNTX) stock is to Strong Buy BNTX stock. Out of 4 analysts , 2 ( 50% ) are recommending BNTX as a Strong Buy, 1 ( 25% ) are recommending BNTX as a Buy, 1 ( 25% ) are recommending BNTX as a Hold, 0 ( 0% ) are recommending BNTX as a Sell, and 0 ( 0% ) are recommending BNTX as a Strong ... Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. BNTX : 98.83 (+0.89%) SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX PR Newswire - Tue Oct 17, 7:35PM CDT. /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ("BioNTech" or the "Company") (NASDAQ: BNTX).Term Box: Best BioNTech SE - ADR forecast, BNTX stock price prediction, BNTX forecast, BioNTech SE - ADR finance tips, BNTX prediction, BioNTech SE - ADR analyst report, BNTX stock price predictions 2023, BioNTech SE - ADR stock forecast, BNTX forecast tomorrow, BioNTech SE - ADR technical analysis, BNTX stock future price, BioNTech SE - ADR projections, BioNTech SE - ADR market prognosis ... The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.The Biontech Se Sponsored Adr stock price fell by -1.01% on the last day (Friday, 1st Dec 2023) from $100.41 to $99.40. During the last trading day the stock fluctuated 5.12% from a day low at $94.78 to a day high of $99.63. The price has been going up and down for this period, and there has been a -0.3% loss for the last 2 weeks.BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.Look out for BNTX's next earnings release expected on March 25, 2024. For the next earning release, we expect the company to report earnings of $3.09 per share, reflecting a year-over-year ...21 Jun 2023 ... BNTX is more profitable, with a gross profit margin and net income margin of 85.29% and 51.08%, respectively, compared to MRNA's 39.82% and ...Although shares of biotech company BioNTech ( BNTX -1.69%) have recently fallen along with most other stocks, the vaccine maker's performance over the past 12 months remains above that of the ...What's Happening with BNTX Stock Today BioNTech SE - ADR (BNTX) stock has risen 7.94% while the S&P 500 is down -1.06% as of 3:50 PM on Tuesday, May 23. BNTX is higher by $8.54 from the previous closing price of $107.50 on volume of 2,063,304 shares. Over the past year the S&P 500 has risen 4.39% while BNTX is down -28.91%.Nov 5, 2021 · Shares of BioNTech ( BNTX -0.31%) were plunging 19.8% as of 11:12 a.m. EDT on Friday. The steep decline came after Pfizer ( PFE 0.50%) announced positive results from a late-stage study of its ... BioNTech (BNTX) stock fell ~5% premarket Aug. 8 after the company's Q2 results missed analysts estimates, however the company reaffirmed its COVID-19 vaccine revenues outlook for...That comes out to about $9.97 and $4.61 billion, respectively. Both metrics topped BNTX stock analysts' forecasts, though earnings fell 24% and sales tumbled 23%.The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole.Now, BNTX stock is currently looking at gains of over 400% in the past year. Could it still have room to run this year? Well, for one thing, the company’s work in the coronavirus vaccine field ...Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued.BioNTech - BNTX - Stock Price Today - Zacks BioNTech (BNTX) (Delayed Data from NSDQ) $97.16 USD -1.67 (-1.69%) Updated Nov 21, 2023 04:00 PM ET After-Market: $97.18 +0.02 (0.02%) 7:58 PM ET...... stock exchange where the shares or rights or certificates representing them are admitted for trading. Global certificates for shares may be issued. Form and ...According to the issued ratings of 10 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $153.69 with a high price target of $260.00 and a low price target of $111.00.BioNTech ADRs drop after JPMorgan lowers outlook to "underweight". Investing.com -- U.S.-listed shares in BioNTech (NASDAQ:BNTX) dipped in early trading on Friday after analysts at JPMorgan ...U. J. Alexander. BioNTech ( NASDAQ: BNTX) said it started a phase 1 trial of an mRNA-based malaria vaccine BNT165b1. BNT165b1 is the first candidate from the company's BNT165 program, to develop a ...The consensus among . 4 Wall Street analysts covering (NASDAQ: BNTX) stock is to Strong Buy BNTX stock. Out of 4 analysts , 2 ( 50% ) are recommending BNTX as a Strong Buy, 1 ( 25% ) are recommending BNTX as a Buy, 1 ( 25% ) are recommending BNTX as a Hold, 0 ( 0% ) are recommending BNTX as a Sell, and 0 ( 0% ) are recommending BNTX as a Strong ...BNTX Stock 12 Months Forecast. $132.67. (38.52% Upside) Based on 12 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $132.67 with a high forecast of $184.00 and a low forecast of $100.00. The average price target represents a 38.52% change from the last price of $95.78.Nov 29, 2023 · Get BioNTech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments 609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...BioNTech SE American Depositary Share (BNTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Debuting at $14.24 per share, BioNTech’s stock price peaked at $112.76 per share on November 10, 2020, when news broke that that company’s vaccination candidate for the novel COVID-19 virus ...Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ... Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. BNTX - BioNTech SE ADR - Stock screener for investors and traders, financial ... Like many other biotech names, BNTX stock has fallen 30 % YTD. Shares are trading at 4.2 times forward earnings and only 1.7 times sales. At present, the 12-month median price forecast for ...The Biontech Se Sponsored Adr stock price fell by -1.01% on the last day (Friday, 1st Dec 2023) from $100.41 to $99.40. During the last trading day the stock fluctuated 5.12% from a day low at $94.78 to a day high of $99.63. The price has been going up and down for this period, and there has been a -0.3% loss for the last 2 weeks.Novavax, Inc. stock has been facing a downward spiral, but there may be a short-term trading opportunity if FDA approval for its COVID-19 vaccine is positive. The high level of short interest in ...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Welcome to our investor page. Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid …Nov 24, 2023 · The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter. ... BioNTech Stock Snapshot. 173.78 Bid. 100.00 Bid Size ... BioNTech SE ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 5:27 a.m. EST Delayed quote $ 97.32 0.46 0.47% Before Hours Volume: 270 Advanced Charting Volume: 492.43K 65...Stocks with records like Novavax's are considered speculative. In the fourth quarter, NVAX stock analysts expect a per-share gain of 16 cents. On an adjusted basis, they expect a 60-cent loss.BNTX stock analysts expected 4.44 billion euros in sales for the year. Germany-based BioNTech noted fewer people are receiving primary vaccinations and population-wide boosting is much lower.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Find the latest Insider Activity data for BioNTech SE American Depositary Share (BNTX) at Nasdaq.com.BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed +26.83 +294.61(+0.82%) Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold...BioNTech ( BNTX ): Despite recent losses, it’s seen as a cheap biotech stock with potential, trading at low free cash flow multiples and projecting healthy upside. Halozyme ( HALO ): Showed ...BNTX Description — BioNTech SE. BioNTech develops immunotherapies for cancer and other diseases. Co.'s immunotherapy product candidates span the following four drug classes: messenger ribonucleic acid (mRNA) therapeutics, in which it is utilizing mRNA to deliver genetic information to cells; cell therapies, in which it is developing a range of cell …Contrarian investors can gain big from these underrated stocks with potential. SentinelOne ( S ): SentinelOne should rise on increasing cyber threats. BioNTech ( BNTX ): BioNTech can leverage its ...Additionally, the market prices BNTX at a forward multiple of 20.52. As a discount to projected earnings, BioNTech ranks better than 66.67% of companies listed in the biotech space. Thus, forward ...7 Aug 2023 ... Amazon's stock has fallen 17% from its 2018, and technical analysis now suggests that shares may rebound. more · High Earners, Not Rich Yet ( ...On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product.Mar 27, 2023 · That comes out to about $9.97 and $4.61 billion, respectively. Both metrics topped BNTX stock analysts' forecasts, though earnings fell 24% and sales tumbled 23%. Stock Price Forecast. According to 13 stock analysts, the average 12-month stock price forecast for BioNTech SE stock is $148.69, which predicts an increase of 50.45%. The lowest target is $111 and the highest is $216. On average, analysts rate BioNTech SE stock as a buy.Like many other biotech names, BNTX stock has fallen 30 % YTD. Shares are trading at 4.2 times forward earnings and only 1.7 times sales. At present, the 12-month median price forecast for ...Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Holder Shares Date Reported % Out Value; Vanguard Horizon Fund-Capital Opportunity Fund: 2,234,636: Sep 29, 2023: 0.94%: 222,122,821: Primecap Odyssey Aggressive ...Nov 29, 2023 · See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. What is BioNTech SE (BNTX)'s stock price today? The current price of BNTX is $98.83. The 52 week high of BNTX is $188.99 and 52 week low is $88.00. When is next earnings date of BioNTech SE (BNTX)?Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued.BNTX.O - | Stock Price & Latest News | Reuters SPX 4,550.58-0.09% IXIC 14,258.49 0.04% 0.32% BioNTech SE BNTX.O Latest Trade 99.25 USD 0 0.00% As of Nov 29, 2023. Values delayed up to 15...See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, ... BNTX Moderna Inc. MRNA Vertex Pharmaceuticals Inc. VRTX Valuation . View More. Metric CRSP BNTXFind the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.BNTX Stock 12 Months Forecast. $132.67. (38.52% Upside) Based on 12 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $132.67 with a high forecast of $184.00 and a low forecast of $100.00. The average price target represents a 38.52% change from the last price of $95.78.CEO. Website. 2008. 5,700. Ugur Sahin. https://www.biontech.de. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is …Find the latest Better Therapeutics, Inc. (BTTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Headquartered in Mainz, Germany, BioNTech SE (NASDAQ:BNTX) is a biotechnology company. On July 3, 2023, BioNTech SE (NASDAQ:BNTX) stock closed at $107.82 per share. One-month return of BioNTech SE ...On this news, BioNTech’s stock price fell $6.61 per share, or 6.38%, to close at $96.97 per share on October 16, 2023. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London ...BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.... BNTX. The Nasdaq Stock Market LLC. Ordinary shares, no par value, with a notional amount attributable to each ordinary share of €1*. —. The Nasdaq Stock Market ...Real time BioNTech Se (BNTX) stock price quote, stock graph, news & analysis.(See BNTX stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a tool that unites all of TipRanks’ equity insights.Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Moreover, Bloomberg.com’s data reveals that the stock currently maintains a consensus rating of “Moderate Buy.” The majority view among investment analysts is that the target price for BNTX stands at approximately $158.69. At present, NASDAQ:BNTX opened at $113.06 on Monday, September 18th.Bntx stocks

609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment .... Bntx stocks

bntx stocks

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.What is the target price for BioNTech (BNTX) stock? The latest price target for BioNTech ( NASDAQ: BNTX) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a ...BioNTech SE ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 5:27 a.m. EST Delayed quote $ 97.32 0.46 0.47% Before Hours Volume: 270 Advanced Charting Volume: 492.43K 65...Wondering where to invest your money? Compare real estate vs. stocks and find the most profitable investment for your financial situation. Compare real estate vs. stocks and find the most profitable investment for your financial situation. ...Among the 386 stocks in the Biotech industry, MRNA is ranked #62, while BNTX is ranked #27. Beyond what is stated above, we have also rated the stocks for Value, Growth, Momentum, Stability, and ...See BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. BNTX - BioNTech SE ADR - Stock screener for investors and traders, financial ... Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ... BioNTech SE (BNTX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioNTech SE | Nasdaq: BNTX | NasdaqOn November 14, 2022, BioNTech SE (NASDAQ:BNTX) stock closed at $160.37 per share. One-month return of BioNTech SE (NASDAQ:BNTX) was 15.42% and its shares lost 35.97% of their value over the last ...Look out for BNTX's next earnings release expected on March 25, 2024. For the next earning release, we expect the company to report earnings of $3.09 per share, reflecting a year-over-year ...However, it's significantly underperforming BNTX stock's YTD return of 258.1%. What was Moderna's FY22 Outlook Presented in FQ3? Moderna presented a reasonably strong FY22 guidance in its FQ3 ...everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we're working on revolutionary approaches in ...Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. BioNTech SE (BNTX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioNTech SE | Nasdaq: BNTX | Nasdaq(RTTNews) - Pharmaceutical giant Pfizer Inc. (PFE) and German biotech firm BioNTech SE (BNTX) announced Wednesday that their mRNA-based COVID-19 v...BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.BNTX : 98.83 (+0.89%) SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX PR Newswire - Tue Oct 17, 7:35PM CDT. /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ("BioNTech" or the "Company") (NASDAQ: BNTX). What is the target price for BioNTech (BNTX) stock? The latest price target for BioNTech ( NASDAQ: BNTX) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a ...Thomas Lohnes. Introduction. In my last article on BioNTech (NASDAQ:BNTX), I primarily focused on its valuation and suggested it might be a good buy ahead of its Q2 results.Since then, the stock ...BioNTech SE American Depositary Share (BNTX) Stock Price, Quote, News & History | Nasdaq MY QUOTES: BNTX Edit my quotes BioNTech SE American Depositary Share (BNTX) 0 Add to Watchlist Add...BNTX Buy Updated on: 16/11/2023. Financial Health. Healthy . Debt to equity ratio: Neutral ... We did not find social sentiment data for this stock. Analyst Ratings. Analyst / firm Rating; Goldman Sachs: Buy: Mani Foroohar Leerink Partners: Sell: Andrew Ang UBS: Buy: Matthew HarrisonWelcome to our investor page. Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.ALNY. Alnylam Pharmaceuticals Inc. 164.01. UNCH. UNCH. Get Moderna Inc (MRNA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.BNTX Stock: Mixed Performance and Challenges in Profitability and Growth. On November 6, 2023, BNTX stock showed mixed performance based on the available data. BNTX is a company in the Health Technology sector, specifically in the Biotechnology industry. With a market cap of $23.2 billion, BNTX is a significant player in the biotech field.Firstly, they can buy shares in companies on the exchanges where they are listed. For instance, investing in BioNTech stocks on the NASDAQ you actually acquire ...BioNTech stock has underperformed the broader markets over the past year and is down more than 29%. However, analysts’ average 12-month price target of $151 implies 33.37% upside potential from current levels. Wall Street analysts remain cautiously optimistic about BNTX stock due to the uncertainty around COVID-19 vaccine demand …Jun 2, 2023 · What happened. Shares of BioNTech ( BNTX 3.25%) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical ... Average Volume (3M) 692.88K. Market Cap. $23.63B. Enterprise Value $9.96B. Total Cash (Recent Filing) €13.88B. Total Debt (Recent Filing) €212.20M. Price to Earnings (P/E) 8.5. Beta 0.70. Next Earnings.Photo by Pascal Bernardon on Unsplash. Worst Performing NASDAQ Stocks In 2023 15. BioNTech SE (NASDAQ:BNTX) Number of Hedge Fund Holders: 22. YTD Share Price Decline as of July 30: 27.74%Biotechs are becoming a dominating force in the healthcare sector. Some scientists believe that we’re in the “golden age” of biotechnology. 2021 was a difficult year for biotech stocks, generally, despite many of those trading at dirt-cheap valuations that don't even reflect the cash they have in hand. It was expected that Biotechs would performInteractive Chart for BioNTech SE (BNTX), analyze all the data with a huge range of indicators.Like many other biotech names, BNTX stock has fallen 30 % YTD. Shares are trading at 4.2 times forward earnings and only 1.7 times sales. At present, the 12-month median price forecast for ...Mar 2, 2022 · Although shares of biotech company BioNTech (BNTX 0.89%) have recently fallen along with most other stocks, the vaccine maker's performance over the past 12 months remains above that of the ... Coupang Inc. Last on the list, Coupang Inc. is a high-profile recent IPO stock to watch. It was the largest foreign company offering since Alibaba ( NYSE: BABA) came public in 2014. The South ...Nov 4, 2021 · Shares of BioNTech (BNTX-1.01%) were 9.1% lower as of 11:51 a.m. EDT on Thursday. The German biotech didn't report any news, so why did its stock slide? ... But stocks that share common ... Debuting at $14.24 per share, BioNTech’s stock price peaked at $112.76 per share on November 10, 2020, when news broke that that company’s vaccination candidate for the novel COVID-19 virus ...Medical - Biomedical and Genetics. $23.493B. $18.242B. BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany. Stock Name. Country. Market Cap.Consider these seven popular names stocks to avoid, as a possible market downturn could knock them down to substantially lower prices. A possible market downturn could knock these stocks down to substantially lower prices Source: Shuttersto...SIGA Technologies, Inc. (NASDAQ:SIGA) ranks 11th in our list of the most undervalued biotechnology stocks to buy according to hedge funds. Insider Monkey’s proprietary database of 920 hedge ...BNTX - BioNTech SE Stock quote - CNNMoney.com Markets Tech Media Success Video BioNTech SE (NASDAQ:BNTX) 99.38 Delayed Data As of 3:59pm ET +1.08 / +1.10% Today’s Change 88.00 Today |||...Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -863.75M. -301.46%. Get the latest Moderna Inc (MRNA) real-time quote, historical ...The analysts downgraded the stock to an Underweight rating from Neutral, with a price target of $99.00, down from the prior $106.00. J.P. Morgan notes the market's cautious stance on the company's ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Photo by Pascal Bernardon on Unsplash. Worst Performing NASDAQ Stocks In 2023 15. BioNTech SE (NASDAQ:BNTX) Number of Hedge Fund Holders: 22. YTD Share Price Decline as of July 30: 27.74%BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.SIGA Technologies, Inc. (NASDAQ:SIGA) ranks 11th in our list of the most undervalued biotechnology stocks to buy according to hedge funds. Insider Monkey’s proprietary database of 920 hedge .... Fda biotech calendar